
Germany indefinitely suspended use of the Oxford-AstraZeneca COVID vaccine for anyone under 60 following advice from STIKO, the country’s independent vaccine committee and external experts. The committee investigated reports of blood clots, some fatal, in people who received the vaccine.
According to the Associated Press, Health Minister Jens Spahn and state officials unanimously agreed to give the vaccine only to people 60 or older unless they belong to a high-risk category where the benefits outweigh the risk of a serious side-effect.
“In sum, it’s about weighing the risk of a side effect that is statistically small, but needs to be taken seriously, and the risk of falling ill with corona,” Spahn told reporters in Berlin.
The European Medicines Agency (EMA) today said they’ve not yet identified any risk factors — such as age, sex or a previous history of blood clotting disorders — associated with the AstraZeneca vaccine.
The EMA issued a new statement reiterating their previous conclusion that the vaccine’s benefits outweigh the risks, but cautioned that people should be aware of the “remote possibility” of rare blood clots occurring, and must seek immediate medical attention in case of symptoms.
The EMA said it “continues to work with the national authorities in the EU Member States to ensure that suspected cases of unusual blood clots are reported” and analyzed.
As The Defender reported Tuesday, several regions of Germany, including Berlin and Munich, temporarily paused the vaccine for people under 60 after Germany’s vaccine regulator disclosed 31 cases of a rare brain blood clot, nine of which resulted in deaths. The decision was made as a precaution ahead of a meeting with national medical regulators scheduled for later in the day yesterday.
